Mustang Bio, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

28 Mar 2025

MBIO

10-K: Mustang Bio's 10-K Filing Reveals Strategic Shift, Financial Challenges

Mustang Bio's latest 10-K filing highlights a strategic focus on CAR T therapies, ongoing clinical trials, and significant financial hurdles, including substantial doubt about its ability to continue as a going concern.

NASDAQ

11 Mar 2024

MBIO

Mustang Bio, INC

10-K: Mustang Bio Details Capital Structure and Regulatory Landscape in 10-K Filing

Mustang Bio's 10-K filing provides a detailed overview of its capital structure, voting rights, and regulatory environment, highlighting its focus on cell and gene therapies.